Omeros Corporation

NASDAQ: OMER
Share price (12/26/24): $10.46
Market cap (12/26/24): $606 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement

Shelf registration

Updated info for already-effective prospectus

Ownership Filter

Borges David J.

Perkinson Diana T.

Hood Leroy E. MD PhD

Hanish Arnold C

News Filter

Omeros’ Narsoplimab Meets Its Pivotal Trial Primary Endpoint – Statistical Analysis Shows Survival Superiority Over External Control in Patients With TA-TMA

Reports Third Quarter 2024 Financial Results – Conference Call Today at 4:30 p.m. ET

Reports Second Quarter 2024 Financial Results – Conference Call Today at 4:30 p.m. ET

Change in Directors, Officers or Compensation, Shareholder Vote Results

Further Strengthens Its Balance Sheet Through Series of Financing Transactions Extending Maturity on a Majority of Its Outstanding Debt Into 2028

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC